Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
CareTech acquisition of Cambian given the all-clear

Specialist care provider CareTech’s acquisition of Cambian will now go ahead after the Competition and Markets Authority (CMA) gave the deal the all-clear.

Under the terms of the reverse merger, CareTech will pay £372 million for Cambian – leaving Cambian shareholders with around 36% of the enlarged company’s shares.

The deal will create Britain’s second biggest social care operator by revenue, controlling 4% a £16 billion UK market.

The CMA launched an investigation in October 2018 amid fears that the acquisition would threaten competition and lead to excessive market power.

Farouq Sheikh, Executive Chairman of CareTech, said: "We are delighted by the CMA's decision and would like to place on record our appreciation to all involved during the CMA process particularly the executive teams at CareTech and Cambian. We will now move forward with the integration, creating value for all our stakeholders through the highest quality service offerings and significant synergies."

Posted on: 08/02/2019

Latest news stories

17/07/2019
Bupa Dental Care acquired 13 new independent practices across the UK and Ireland in 2019, taking the company’s total to 483 sites.
16/07/2019
The sale of Barchester Healthcare to Australian bank Macquarie has collapsed amid uncertainty over Brexit.
16/07/2019
Retirement communities have a major role to play in meeting the housing and care needs of our ageing population according to care minister Caroline Dinenage.
15/07/2019
August Equity has sold specialist care provider Aspirations Care to Elysian Capital for an undisclosed sum
15/07/2019
SBRI Healthcare today announced it has awarded more than £5.56 million in funding to six pioneering medtech innovations in the fields of mental health and surgery.


Civica


HealthInvestor blog
The dismal story of abuse by staff at a private sector specialist care unit is depressingly familiar. While the operator is clearly culpable, why did the regulator and other independent bodies also fail these vulnerable patients?

Click here to view the HealthInvestor blog


A lawyer who, as part of Freeths’ care team, enjoys practising within the care sector and working exclusively on transactions
The dentistry sector has proved to be a sweet spot for investors with some market-leading groups transacting for impressive multiples. But is the top segment of the market now closed for business? Marie Cahalane reviews the current landscape
Retirement living is a sector where future demand outstrips supply and the market opportunity is said to reach the £100 billion mark. Marie Cahalane speaks to Phil Bayliss, chief executive of later living at Legal & General, about the group’s new endeavour Guild Living – a developer and operator of urban later living communities
Telehealth is entering a new phase – IP-enabled technology. Tunstall Healthcare, under the guidance of chief executive Gordon Sutherland, is making the tech-transformation and supporting new models of care delivery. Marie Cahalane learns more
It’s estimated that 1.5 million people in the UK have a learning disability, of which 350,000 have a severe disability. Technology and innovation can improve their lives and allow them to live as independently as possible. Daniel Casson is digital development executive for Care England and part of the team delivering NHS Digital’s digital social care programme

Click here to search all feature articles



Interview: Tunstall Healthcare

Telehealth is entering a new phase - IP-enabled technology. Tunstall Healthcare, under the guidance of chief executive Gordon Sutherland, is making the tech-transformation and supporting new models of care delivery. Marie Cahalane learns more
Read more


Christie + Co

my images



Veterinary services
The UK veterinary sector has attracted investor interest for some years now, thanks to factors such as rising spending on pet care and there's been rapid consolidation with sky-rocketing valuations. But can these trends continue asks Catherine Gooderham?
Read more